In summary, this study analyzed the differences of serum VEGF, hs-CRP, and Cys-C in type 2 DR patients with HUA and normal UA levels, and their relationships between UA, which was helpful to pay more attention to UA levels in T2DM patients in clinical work, to reduce the occurrence and development of DR. This evidence concerns the gene VEGFA and type 2 diabetes mellitus.